Project description
On the 12th of Mars 2020 Norwegian authorities decided to lock down the society due to the COVID-19 pandemic. Due to the lack of an effective conventional treatment for COVID-19, people might use unconventional therapies more often than they did before the pandemic. The aim of this study was therefore to determine the prevalence and associations for use of unconventional therapies during the first wave of the COVID-19 pandemic among a representative sample of adult women and men in Norway.
How we are conducting the study
We surveyed 1008 Norwegians aged 16 and above (stratified by sex, age and region of residence) in collaboration with Ipsos A/S. This was carried out between April and May 2020. The final sample included 1008 individuals, where 487 were women and 521 were men.
Our partners
NAFKAM is collaborating with researchers from the Netherlands (Louis Bolk Institute, and Dutch Consortium for Integrative Medicine and Health) and Sweden (Regional Cancer Center Stockholm, and Karolinska University Hospital) in this study.
Contact person: Agnete Egilsdatter Kristoffersen
